Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2012

01.04.2012 | Article

Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore

verfasst von: C.-L. Yeo, D. S.-G. Chan, A. Earnest, T.-S. Wu, S.-F. Yeoh, R. Lim, R. Jureen, D. Fisher, L.-Y. Hsu

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

We evaluated the impact of a prospective audit and feedback antimicrobial stewardship program (ASP) on antibiotic prescription and resistance trends in a hematology-oncology unit in a university hospital (National University Cancer Institute, Singapore [NCIS]). A prospective interrupted time-series study comprising 11-month pre-intervention (PIP) and intervention evaluation phases (IEP) flanking a one-month implementation phase was carried out. Outcome measures included defined daily dose per 100 (DDD/100) inpatient-days of ASP-audited and all antibiotics (encompassing audited and non-audited antibiotics), and the incidence-density of antibiotic-resistant microorganisms at the NCIS. Internal and external controls were DDD/100 inpatient-days of paracetamol at the NCIS and DDD/100 inpatient-days of antibiotics prescribed in the rest of the hospital. There were 580 ASP recommendations from 1,276 audits, with a mean monthly compliance of 86.9%. Significant reversal of prescription trends towards reduced prescription of audited (coefficient = −2.621; 95% confidence interval [CI]: −4.923, −0.319; p = 0.026) and all evaluated antibiotics (coefficient = −4.069; 95% CI: −8.075, −0.063; p = 0.046) was observed. No changes were seen for both internal and external controls, except for the reversal of prescription trends for cephalosporins hospital-wide. Antimicrobial resistance did not change over the time period of the study. Adverse outcomes—the majority unavoidable—occurred following 5.5% of accepted ASP recommendations. Safe and effective ASPs can be implemented in the complex setting of hematology-oncology inpatients.
Literatur
1.
Zurück zum Zitat Dellit TH, Owens RC, McGowan JE Jr et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177PubMedCrossRef Dellit TH, Owens RC, McGowan JE Jr et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177PubMedCrossRef
2.
Zurück zum Zitat Allerberger F, Mittermayer H (2008) Antimicrobial stewardship. Clin Microbiol Infect 14:197–199PubMedCrossRef Allerberger F, Mittermayer H (2008) Antimicrobial stewardship. Clin Microbiol Infect 14:197–199PubMedCrossRef
3.
Zurück zum Zitat Rolston KV (2009) The use of new and better antibiotics for bacterial infections in patients with leukemia. Clin Lymphoma Myeloma 9(Suppl 3):S357–S363PubMed Rolston KV (2009) The use of new and better antibiotics for bacterial infections in patients with leukemia. Clin Lymphoma Myeloma 9(Suppl 3):S357–S363PubMed
4.
Zurück zum Zitat Metjian TA, Prasad PA, Kogon A et al (2008) Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J 27:106–111PubMed Metjian TA, Prasad PA, Kogon A et al (2008) Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J 27:106–111PubMed
5.
Zurück zum Zitat Agwu AL, Lee CK, Jain SK et al (2008) A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis 47:747–753PubMedCrossRef Agwu AL, Lee CK, Jain SK et al (2008) A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis 47:747–753PubMedCrossRef
6.
Zurück zum Zitat Cheng VC, To KK, Li IW et al (2009) Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital. Eur J Clin Microbiol Infect Dis 28:1447–1456PubMedCrossRef Cheng VC, To KK, Li IW et al (2009) Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital. Eur J Clin Microbiol Infect Dis 28:1447–1456PubMedCrossRef
7.
Zurück zum Zitat Jin J, Lee YM, Ding Y et al (2010) Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore. Ann Acad Med Singapore 39:453–459PubMed Jin J, Lee YM, Ding Y et al (2010) Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore. Ann Acad Med Singapore 39:453–459PubMed
9.
Zurück zum Zitat Clinical Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing. Supplement M100-S14. CLSI, Wayne, PA, USA Clinical Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing. Supplement M100-S14. CLSI, Wayne, PA, USA
10.
Zurück zum Zitat Hsu LY, Tan TY, Jureen R et al (2007) Antimicrobial drug resistance in Singapore hospitals. Emerg Infect Dis 13:1944–1947PubMed Hsu LY, Tan TY, Jureen R et al (2007) Antimicrobial drug resistance in Singapore hospitals. Emerg Infect Dis 13:1944–1947PubMed
11.
Zurück zum Zitat Fraser GL, Stogsdill P, Dickens JD Jr et al (1997) Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 157:1689–1694PubMedCrossRef Fraser GL, Stogsdill P, Dickens JD Jr et al (1997) Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 157:1689–1694PubMedCrossRef
12.
Zurück zum Zitat Carling P, Fung T, Killion A et al (2003) Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24:699–706PubMedCrossRef Carling P, Fung T, Killion A et al (2003) Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24:699–706PubMedCrossRef
13.
Zurück zum Zitat Bantar C, Sartori B, Vesco E et al (2003) A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 37:180–186PubMedCrossRef Bantar C, Sartori B, Vesco E et al (2003) A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 37:180–186PubMedCrossRef
14.
Zurück zum Zitat Wong-Beringer A, Nguyen LH, Lee M et al (2009) An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse. Pharmacotherapy 29:736–743PubMedCrossRef Wong-Beringer A, Nguyen LH, Lee M et al (2009) An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse. Pharmacotherapy 29:736–743PubMedCrossRef
15.
Zurück zum Zitat Yong MK, Buising KL, Cheng AC et al (2010) Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother 65:1062–1069PubMedCrossRef Yong MK, Buising KL, Cheng AC et al (2010) Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother 65:1062–1069PubMedCrossRef
16.
Zurück zum Zitat Cook PP, Catrou PG, Christie JD et al (2004) Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 53:853–859PubMedCrossRef Cook PP, Catrou PG, Christie JD et al (2004) Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 53:853–859PubMedCrossRef
17.
Zurück zum Zitat Hsu LY, Tan TY, Tam VH et al (2010) Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 54:1173–1178PubMedCrossRef Hsu LY, Tan TY, Tam VH et al (2010) Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 54:1173–1178PubMedCrossRef
18.
Zurück zum Zitat Joshi VD, Lim JF (2010) Health insurance in Singapore: who’s not included and why? Singapore Med J 51:399–405PubMed Joshi VD, Lim JF (2010) Health insurance in Singapore: who’s not included and why? Singapore Med J 51:399–405PubMed
19.
Zurück zum Zitat Owens RC Jr, Fraser GL, Stogsdill P, Society of Infectious Diseases Pharmacists (2004) Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 24:896–908PubMedCrossRef Owens RC Jr, Fraser GL, Stogsdill P, Society of Infectious Diseases Pharmacists (2004) Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 24:896–908PubMedCrossRef
Metadaten
Titel
Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore
verfasst von
C.-L. Yeo
D. S.-G. Chan
A. Earnest
T.-S. Wu
S.-F. Yeoh
R. Lim
R. Jureen
D. Fisher
L.-Y. Hsu
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1351-6

Weitere Artikel der Ausgabe 4/2012

European Journal of Clinical Microbiology & Infectious Diseases 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.